Broncus 

$0.080000
0
+$0.00+0% Tuesday 20:00

Statistics

Day High
0.08
Day Low
0.08
52W High
0.08
52W Low
0.08
Volume
10,000
Avg. Volume
0
Mkt Cap
40.05M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

27AugExpected
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
-0.02
0.31
0.65
0.98
Expected EPS
N/A
Actual EPS
-0.02

Financials

-10,272.99%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
174,000Revenue
-17.88MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Broncus Holding Corporation is a medical technology enterprise dedicated to advancing interventional pulmonology through the development of specialized products. Its operational reach extends across key markets including Mainland China, the European Union, the United States, and other international regions. The company's product portfolio is broadly categorized into navigation and treatment solutions. Navigation offerings include: LungPoint Virtual Bronchoscopic Navigation: A sophisticated, computer-assisted software system that utilizes imaging for virtual bronchoscopic guidance. LungPoint Plus: This system provides real-time navigational assistance within the airways, crucial for lung biopsies and various other pulmonological procedures. LungPro: A virtual bronchoscopic navigation tool that facilitates three-dimensional, real-time guided transbronchial needle aspiration and features proprietary parenchymal navigation capabilities. Its comprehensive suite of treatment products comprises: InterVapor: A targeted bronchoscopic thermal vapor ablation method designed to treat diseased, hyper-inflated lung segments. RF Generator + RF Ablation Catheter: A radiofrequency ablation system specifically engineered for use with a disposable lung radiofrequency ablation catheter, targeting lung cancer. H-Marker: A specialized marker for pulmonary surgical applications. Furthermore, Broncus provides essential procedural accessories and tools such as: BioStarNeedle: A single-use, ultrasound-guided aspiration needle for efficiently collecting tissue samples. FleXNeedle: A versatile biopsy needle adaptable for multiple purposes. Archimedes Sheath: A sterile, single-use flexible tube that establishes a working channel during bronchoscopic interventions. Archimedes Dilation Balloon: A sterile, single-use flexible tube equipped with a balloon at its tip, inserted via a bronchoscope or sheath to dilate targeted lung tissue within the bronchial tree. Steerable Sheath: Featuring a steerable adjustment handle and a working channel for enhanced maneuverability. Broncus Holding Corporation was established in 2012 and maintains its corporate headquarters in Hangzhou, China.
Show more...
CEO
Hong Xu
Employees
191
Country
Cayman Islands
ISIN
KYG1609T1022

Listings

0 Comments

Share your thoughts

FAQ

What is Broncus stock price today?
The current price of BRNHF is $0.08 USD — it has increased by +0% in the past 24 hours. Watch Broncus stock price performance more closely on the chart.
What is Broncus stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Broncus stocks are traded under the ticker BRNHF.
Is Broncus stock price growing?
BRNHF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Broncus has showed a +0% increase.
What is Broncus market cap?
Today Broncus has the market capitalization of 40.05M
When is the next Broncus earnings date?
Broncus is going to release the next earnings report on March 31, 2027.
What were Broncus earnings last quarter?
BRNHF earnings for the last quarter are -0.02 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Broncus revenue for the last year?
Broncus revenue for the last year amounts to 174,000 USD.
What is Broncus net income for the last year?
BRNHF net income for the last year is -17.88M USD.
How many employees does Broncus have?
As of September 04, 2026, the company has 191 employees.
In which sector is Broncus located?
Broncus operates in the Health & Wellness sector.
When did Broncus complete a stock split?
Broncus has not had any recent stock splits.
Where is Broncus headquartered?
Broncus is headquartered in Hangzhou, Cayman Islands.